2.Curative effect analysis of ultrashort wave combined with dephlogisticate cholagogue table in treating patients with chronic cholecystitis
Chinese Journal of Postgraduates of Medicine 2012;35(18):28-30
Objective To evaluate the clinical effect of ultrashort wave combined with dephlogisticate cholagogue table in treating patients with chronic cholecystitis.Methods One hundred and forty-four patients with chronic cholecystitis treated from January 2009 to October 2011 were randomly divided into 2gtoupe by mechanical sampling method.Treatment group (76 cases) was treated with ultrashort wave and dephlogisticate cholagogue table.Control group (68 cases) was treated with dephlogisticate cholagogue table.The therapeutic effect and the incidence of ache and fever and B-type ultrasonography between two groups were compared.Results The total effective rates were 89.5% (68/76) in treatment group and 67.6%(46/68) in control group.There was significant difference (P <0.01).The incidence of ache and fever,positive rate of B-type ultrasonography in tneatment group [10.5%(8/76),5.3%(4/76),10.5%(8/76)] were significantly lower than those in control group [32.4% (22/68),14.7% (10/68),33.8%(23/68)] (P < 0.05).Conclusion Ultrashort wave combined with dephlogisticate cholagogue tabble is an effective method for treating chronic cholecystitis.
3.Biological markers of esophageal carcinoma invasion and metastasis
Journal of International Oncology 2011;38(10):774-776
The invasion and metastasis of esophageal carcinoma is associated with several tumor marker on oncogenesi and tumor development,including matrix metalloproteinase,cell adhesion molecules CD44,pituitary-tumour transforming genes.Studies have shown that these tumor markera are over-expression in esophageal carcinoma,which affect the progress and prognosis of esophageal carcinoma,and their specificity and value for clinical application need to be futher studied.
4.Reliability and validity of Chinese version of the Medication Adherence Self-efficacy Scale
Chinese Journal of Practical Nursing 2015;31(20):1502-1505
Objective To translate the English version of the Medication Adherence Self-efficacy Scale (MASES) into Chinese and to test the reliability and validity of the Chinese version of MASES in patients with hypertension.Methods Totally 285 patients with hypertension were recruited and were investigated by the Chinese version of MASES.The results underwent analysis for reliability and validity.Results The retest reliability of MASES was 0.843.The Cronbach α of the Chinese version of MASES was 0.876.The Cronbach α of the four dimensions ranged from 0.794 to 0.905.The average content vality index (CVI) of the scale was 0.946.Factor analysis got four factors,which explained 68.683% of the total variance.The factor loading of each item on its common factor was >0.4.Conclusions The Chinese version of MASES has been proved to be reliable and valid.It can be used as a valid tool for the measurement of the patient compliance in patients with hypertension.
5.Reliability and validity of Chinese version of the Oncology Patients' Perceptions of the Quality of Nursing Care Scale
Chinese Journal of Practical Nursing 2015;31(23):1770-1773
Objective To translate the English version of the Oncology Patients' Perceptions of the Quality of Nursing Care Scale (OPPQNCS) into Chinese and to test the reliability and validity of the Chinese version of OPPQNCS in oncology patients.Methods The English version of OPPQNCS was translated by Brislin translation mode.Totally 320 oncology patients were recruited and were investigated by the Chinese version of OPPQNCS.Results The internal consistency coefficient of the Chinese version of OPPQNCS was more than 0.70,ranged from 0.804 to 0.964;the test-retest was 0.826.The content validity index(CVI) was 0.845-1.000,the average CVI was 0.925.Factor analysis got four factors,which explained 78.548% of the total variance.And every objective factor loading were greater than 0.4.Conclusions The Chinese version of OPPQNCS has been proved to be reliable and valid.It can be used as a valid tool for the oncology patients to measure their perceptions of the quality of nursing care they got.
6.Association between serum uric acid levels and prognosis in acute ischemic stroke:a prospective case study
Chinese Journal of Geriatrics 2015;34(11):1210-1212
Objective To investigate the association between serum uric acid (SUA)levels and outcome in acute ischemic stroke.Methods A total of 388 acute ischemic stroke patients were included in the prospective case study.Data on demographic characteristics, risk factors for life style, history of disease, the admission SUA and outcome at discharge were collected for all participants.Results Mean serum uric acid levels were (284.5±83.6) μmol/L in the normal uric acid? group, and(455.3±78.1)μmol/L in the high uric acid group(P<0.01).There were significant differences in National Institutes of Health Stroke Scale (NIHSS) score at two weeks between the high UA group and the normal UA group [(11.0±6.0) vs.(11.0±5.3),P=0.048], and also in early neurological improvement (P=0.048).A significant difference was found in serum uric acid level between patients with good versus poor neurological function outcome (P =0.045).Conclusions There is the association between admission serum uric acid levels and outcome in acute ischemic stroke.Elevated serum uric acid level predicts a lower chance of a poor outcome in acute ischemic stroke.
7.Recent advances of molecular genetic characteristics of small cell lung cancer
China Oncology 2014;(8):630-635
Small cell lung cancer (SCLC) is an aggressive malignancy with fairly poor prognosis. Innovative treatment based on improved understanding of the genetic alterations of SCLC is awaited. Recently, a number of potential targets or important oncogenic pathways have been identified by the next generation sequencing or other systematic genomic analysis in SCLC. In this review, we summarised the new ifndings of genetic characteristics in SCLC.
8.Expression and clinical significance of survivin and p63 in diffuse large B-cell lymphoma
Journal of Leukemia & Lymphoma 2010;19(4):219-221
Objective To investigate the expression and significance of survivin and p63 in diffuse large B-cell lymphoma (DLBCL). Methods Immunohistochemical staining was used to detect the expression of survivin and p63 in the lymphnode tissues from DLBCL patients and lymph node reactive proliferation.Results The positive expression rate of p63 and survivin proteins in DLBCL patients was 63.5 %(33/52) and 76.9 %(40/52), respectively. p63 was not expressed in lymph node reative proliferation. The positive expression rate of survivin in lymph node reactive proliferation was 20.0 %. The expression rates of survivin and p63 between two groups was significant different. The replase rate of groups with positive expression of survivin and p63 were higher than that of the negative groups. The mean survival in groups with positive expression of survivin and p63 were shorter than that of the negative groups. Conclusion Survivin and p63 are useful in therapeutic and prognostic assessment. Patients with poor prognostic can be screened out in the early period of treatment using expression of survivin and p63, which may help to improve the outcome of diffuse large B-cell lymphoma.
9.The current situation and prospects for the application of clinical pathways to domestic hospital management
Chinese Journal of Hospital Administration 1996;0(07):-
By analyzing the current situation of the application of clinical pathways in China, the paper reviews the achievements that have been made via the application of clinical pathways to the domestic management of patient care, nursing, pharmacy and operation and discusses the problems existing in such application. It argues that there are sound prospects for the application of clinical pathways to hospital management.
10.Expression and modulation of connective tissue growth factor in renal interstitial fibrosis
Chinese Journal of Pathophysiology 1999;0(09):-
CTGF, a member of the CCN family of immediate early genes, is a recently discovered profibrotic growth factor, which is involved in many pathophysiologic procedures. CTGF acts as a downstream effector of TGF-? acting on interstitial cells to enhance the progression of fibrotic renal diseases. It has been shown that CTGF gene expression can be induced or blocked by some kinds of cytokine and drugs. It is an interesting candidate target for future intervention strategies of renal interstitial fibrosis. [